 |
|
 |
Denmark |
|
|
The Pharmaceutical Market: Denmark
Publication Date April 2007
Publisher Espicom
Product Type Strategic Report
Pages 94
ISBN Number not applicable
Product Code ESP853
|
|
|
Summary
Denmark is the home of a global leader in the manufacture of insulin and as a consequence has retained a healthy balance of payments surplus for the past five years; in 2004, the surplus was in excess of US$3.3 billion.
Prior to April 2005, there was a price freeze on pharmaceuticals and reimbursement levels were based upon reference prices in other northern European countries. Since then, reimbursement levels for each class have been based on the cheapest generic drug. This has led to LiF, the Danish pharmaceutical trade association, to query how long the price freeze can be maintained, especially as there is a constant downward pressure on prices.
There is strong domestic production although many producers focus on Denmark's export market, therefore much of pharmaceutical imports are in retail-ready packages.
These pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
Background Data
- Geography
- Political Overview
- Economic Overview
- Population
- Population Trends, 2001-2011
- Population by Region & Gender, 2005
- Population by Age & Gender, 2005
- Demographic Indicators
- Demographic Indicators, 2000-2004
- Mortality
- Morbidity
- Cancer Incidence
- Most Common Types of Cancer Among Male (New Cases), 2003
- Most Common Types of Cancer Among Female (New Cases), 2003
- Hiv / Aids
- Diagnosed Cases of AIDS, 1999-2004
- Charts
- Map of Denmark
- Population by Age, 2005 (%)
- Causes of Death, 2001 (%)
Healthcare System
- Organisation & Administration
- Health Expenditure
- Hospital Services
- Hospital Resources
- Hospitals by Type, 2002
- Hospitals by Region, 2002
- Hospital Beds by Region, 1993-2002
- Hospital Beds by Specialty, 2002
- Hospital Beds by Specialty, 1996-2000
- Hospital activity by Year, 2000-2003
- Hospital Activity Summary by ICD-10 Classification and Year, 2002-2003
- Hospital Patients, 2002-2003
- Hospital Admissions, 2002-2003
- Average length of Stay, 2002-2003
- Private Hospitals
- Ambulatory Care
- Outpatient Activity by Region, 2002
- Outpatient Activity by Specialty, 2002
- Medical Personnel
- Hospital Medical Personnel, 1990-1999
- Primary Sector Medical Personnel, 1990-1999
- Charts
- Central Government Expenditure on Health, 2000-2004
- Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
- Centralised Procedure
- The EMEA
- Mutual Recognition Procedure
- Pharmaceutical Registration
- Clinical Trials
- Advertising
- Patent Protection & Intellectual Property Rights
- Supplementary Protection Certificates
- Pricing and Reimbursement
- Pricing
- Generic substitution
- Reimbursement
- Relationship Between Annual Consumption and Pharmaceutical Reimbursement, 2005
- Distribution Channels
- Pharmacies, 1990 - 2004
- Distributors
- Amgros
- Dupharma
- Missionpharma
- Pharmaceutical Imports
- Pharmaceutical Import Trends, 2003-2004 (US$000s)
- Leading Suppliers of Raw Materials, 2004 (US$000s)
- Leading Suppliers of Medicaments, 2004 (US$000s)
- Pharmaceutical Imports, 2000-2004 (US$000s)
- Pharmaceutical Import Trends, 2004 (US$000s)
- Leading Suppliers, 2004 (US$000s)
- Leading Suppliers by Category, 2004 (US$000s)
- Parallel Imports
- Domestic Production
- Domestic Pharmaceutical Manufacturing Turnover, 2000-2004
- Trade Associations
- Domestic Producers
- ALK-Abell
- Hexal A/S
- Leo Pharma
- Lundbeck A/S
- Novo Nordisk
- PharmaDanica
- Genmab A/S
- Pharmexa
- Research & Development
- Pharmaceutical Research & Development Expenditure by Lif's Member Companies, 1990-2000 (DKr
- Million)
- Exports
- Summary of Pharmaceutical Exports, 2000-2004 (US$000s)
- Leading Destinations, 2004 (US$000s)
- Pharmaceutical Exports, 2000-2004 (US$000s)
- Pharmaceutical Export Trends, 2004 (US$000s)
- Leading Destinations, 2004 (US$000s)
- Balance of Trade, 2000-2004 (US$000s)
- Directory
- Government Organisations
- Trade Associations
- Charts
- Leading Suppliers, 2004 (%)
|
|
|
